Paul Dillon

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 906 citations

Metabolic Syndrome, Hepatology, Nonalcoholic Fatty Liver Disease +9

Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents

Mark A Bellis, Karen Hughes, Paul Dillon et al. · BMC Public Health · 2007 · 523 citations · Full text

Ecstasy use in Australia: patterns of use and associated harm

Libby Topp, Julie Hando, Paul Dillon et al. · Drug and Alcohol Dependence · 1999 · 356 citations

Substance Abuse, Substance Use, Health Policy +12

Patterns of use and harms associated with non-medical ketamine use

Paul Dillon · Drug and Alcohol Dependence · 2003 · 246 citations

Drug Safety, Substance Abuse, Addiction +12

GHB use among Australians: characteristics, use patterns and associated harm

Louisa Degenhardt, Shane Darke, Paul Dillon · Drug and Alcohol Dependence · 2002 · 152 citations

Substance Abuse, Health Effect, Substance Use +9